CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for iAnthus Capital Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

iAnthus Capital Holdings Inc
420 Lexington Ave, Suite 414
Phone: (646) 518-9418p:646 518-9418 NEW YORK, NY  10170  United States Ticker: IANIAN
Business Summary
iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes-YesYes

Industries
SIC Code Description
0182 Food crops grown under cover
2833 Medicinal chemicals and botanical products
5159 Farm-product raw materials, not elsewhere classified
5912 Drug stores and proprietary stores

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
CEO and Director HadleyFord
Chief Executive Officer, Director RichardProud 44 7/17/2023 7/17/2023
President and Director RandyMaslow
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Organix, LLC 1795 Airport Road Breckenridge CO United States
CannaTech Medicinals, Inc. 1032 E BRANDON BLVD BRANDON FL US
MPX New Jersey LLC 11 Devins Ln Pleasantville NJ United States
CBD For Life 8 Sailors Way Red Bank NJ United States
MPX Bioceutical Corp. 5255 Yonge Street North York ON Canada

Business Names
Business Name
Ambary, LLC
Cannatech Medicinals Inc.
Cave Creek
42 additional Business Names available in full report.

General Information
Outstanding Shares: 6,615,326,267 (As of 4/5/2024)
Shareholders: 548
Stock Exchange: CNQ
Fax Number: (778) 329-9361


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024